PUBLICATIONS

Inhibitory mechanisms of very low–dose rivaroxaban in non–ST-elevation myocardial infarction

No.37
CitationBlood Adv 2(6),p715-730(2018)
InstituteUniversity of Tübingen
1st AuthorO Borst
AR
PL
HD
Paper typesClinical investigations
Main
purpose
Drug efficacy evaluation
DiseaseACS
Antiplatelet drugAspirin, Clopidogrel, Ticagrelor
Anticoagulant drugRivaroxaban
Other drug
Clinical specimens
Animal
Keyword
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.